Targeting Egr-1 with Curcumin Analogs for Prostate Cancer Prevention Bisoffi, Marco Project Summary The problem addressed in this proposal: Field cancerization, i.e. the presence of genetic and biochemical abnormalities in histologically normal tissues outside the tumor margins, may indicate a status of pre- malignancy in prostatic tissues that set the stage for tumor development. By definition, detectable molecular alterations in these tissues can represent early biomarkers of disease, even before disease is manifested histologically and long before a clinical problem arises. In addition, some of these changes, because of their early appearance, might be clinically useful targets for prevention, such as for example by dietary ingredients. While this concept has long been recognized for prominent compounds, such as from green tea (Epigallocatechin-3-gallate), tomatoes (Lycopene), grapes (Resveratrol), and Turmeric (Curcumin), the identification of the underlying mechanisms still awaits elucidation. Description of the investigation: We have identified an elevated expression of the transcription factor early growth response protein 1 (Egr-1) in tumor adjacent histologically normal prostatic tissues through gene array analysis, and confirmed our initial observation by reverse transcriptase polymerase chain reaction. We hypothesize that Egr-1 expression is not only indicative of prostatic field cancerization, but also represents a suitable target for defining new preventive strategies. We have assembled a multidisciplinary team of basic and clinical researchers to address the two following Specific Aims:
Aim 1 : Determine the expression of Egr-1 in pre-malignant, disease-free prostatic tissues. This will answer the question of whether Egr-1 expression is elevated in prostatic tissue at risk of tumor initiation.
Aim 2 : Identify lead compounds of Curcumin analogs inhibitory for Egr-1 expression. This will answer the question of whether Egr-1 expression can be regulated by natural dietary products. Importance of the investigation: Population based epidemiological studies indicate that dietary ingredients and natural products act as preventive agents such as Curcumin for prostate cancer. However, the underlying mechanisms are not known in most of the cases. A detailed understanding of these mechanisms is of utmost importance, as it will identify suitable targets and provide avenues towards the development of specific and directed prevention strategies. The present proposal contributes to the development of more effective strategies for prostate cancer prevention, thereby addressing the annual incidence rate of approximately 220,000 men in the United States alone. Targeting Egr-1 with Curcumin Analogs for Prostate Cancer Prevention Bisoffi, Marco Project Narrative The first phase of our project is designed to test the validity of a molecule termed Egr-1 that we found abnormally expressed in prostatic tissues adjacent to tumors. We hypothesize that abnormal Egr-1 expression indicates pre-malignancy and sets the stage for tumor development. In the second phase, we will identify analog compounds of the natural product Curcumin (found in Indian spices, such as Turmeric, Curry) that are capable of inhibiting Egr-1 expression. We expect that such novel and potent compounds will ultimately lead to clinical trials for prostate cancer prevention using dietary supplements. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
1R03CA136030-01
Application #
7545393
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (M1))
Program Officer
Perloff, Marjorie
Project Start
2008-07-01
Project End
2010-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
1
Fiscal Year
2008
Total Cost
$75,000
Indirect Cost
Name
University of New Mexico
Department
Biochemistry
Type
Schools of Medicine
DUNS #
868853094
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Gabriel, Kristin N; Jones, Anna C; Nguyen, Julie P T et al. (2016) Association and regulation of protein factors of field effect in prostate tissues. Int J Oncol 49:1541-1552
Jones, Anna C; Antillon, Kresta S; Jenkins, Shannon M et al. (2015) Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. PLoS One 10:e0119314
Jones, Anna C; Trujillo, Kristina A; Phillips, Genevieve K et al. (2012) Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate 72:1159-70
Fajardo, Alexandra M; MacKenzie, Debra A; Ji, Ming et al. (2012) The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells. Prostate 72:612-25
Heaphy, Christopher M; Bisoffi, Marco; Joste, Nancy E et al. (2009) Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Res Treat 117:17-24